3D Printed Personalized Extendable Prosthesis
1 other identifier
observational
25
1 country
1
Brief Summary
The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 18, 2023
CompletedFirst Posted
Study publicly available on registry
April 3, 2023
CompletedApril 3, 2023
March 1, 2023
7.3 years
March 18, 2023
March 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrence
Osteosarcoma recurrence rate
7years
Study Arms (2)
3D printed
3D printed personalized extendable prosthesis replacement for limb preservation in children with osteosarcoma
amputation
patients had undergone amputation of the limbs
Interventions
3D printed personalized extendable prosthesis replacement for limb preservation in children
Eligibility Criteria
children with osteosarcoma undergoing prosthesis replacement or limb amputation were admitted to our hospital
You may qualify if:
- tumors of the extremities, with moderate soft-tissue invasion
- the neurovascular bundle is not invaded, and the tumor can be excised totally
- no metastatic lesions or metastases can be cured
You may not qualify if:
- recurrent tumors
- poorly differentiated tumors
- poor soft-tissue conditions
- neurovascular invasion around tumors
- ineffective chemotherapy with metastasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yuxi Sulead
Study Sites (1)
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400014, China
Study Officials
- PRINCIPAL INVESTIGATOR
Yuxi Su
Children's Hospital of Chongqing Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Children's Hospital of Chongqing Medical University
Study Record Dates
First Submitted
March 18, 2023
First Posted
April 3, 2023
Study Start
October 1, 2015
Primary Completion
January 1, 2023
Study Completion
March 1, 2023
Last Updated
April 3, 2023
Record last verified: 2023-03